Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Schizophrenia
78%
Patients with Schizophrenia
61%
Treatment-resistant Schizophrenia
53%
Meta-analysis
50%
Healthy Controls
48%
Antipsychotics
46%
Alzheimer's Disease
40%
Alzheime's Disease
40%
Transcranial Magnetic Stimulation
37%
Inpatient Treatment
33%
Treatment-resistant Depression
33%
Major Depressive Disorder
29%
Glutamatergic
28%
Neurometabolites
26%
Proton Magnetic Resonance Spectroscopy
25%
Clozapine
24%
AMPA Receptor (AMPAR)
21%
Glutamate
20%
Depressive Symptoms
20%
Dopamine D2/3 Receptor
19%
Mild Cognitive Impairment
18%
Electroencephalography
18%
Healthy Individuals
18%
Positron Emission Tomography/computed Tomography (PET/CT)
17%
Spectroscopy Studies
17%
Bipolar Disorder
16%
Antidepressants
16%
Repetitive Transcranial Magnetic Stimulation (rTMS)
15%
Intervention Effectiveness
15%
Dorsolateral Prefrontal Cortex (DLPFC)
14%
Ketamine
14%
Striatal Dopamine
13%
Psychosis
13%
Neuropsychiatric Symptoms
13%
Japan
13%
1H-MRS
12%
Patients with Depression
12%
Stimulation Treatment
12%
Receptor Availability
12%
Autism Spectrum Disorder
11%
Olanzapine
11%
Treatment Response
11%
Treatment Resistance
11%
Glutamine
11%
Anterior Cingulate Cortex
11%
Intermittent theta Burst Stimulation (iTBS)
11%
Dorsal Anterior Cingulate Cortex (dACC)
11%
Raclopride
10%
Ventral Striatum
10%
Receptor Occupancy
10%
Neuroscience
Schizophrenia
100%
Systematic Review
65%
Transcranial Magnetic Stimulation
49%
Treatment-Resistant Schizophrenia
45%
Antipsychotic
43%
Meta-Analysis
41%
Alzheimer's Disease
40%
Dopamine
32%
Glutamic Acid
31%
Nuclear Magnetic Resonance Spectroscopy
28%
Receptor
28%
Positron Emission Tomography
27%
Treatment-Resistant Depression
26%
Electroencephalography
25%
Clozapine
23%
Major Depressive Disorder
21%
Mild Cognitive Impairment
19%
Dorsolateral Prefrontal Cortex
17%
Bipolar Disorder
17%
AMPA Receptor
16%
Antidepressant
15%
Anterior Cingulate Cortex
15%
Psychosis
15%
Magnetic Resonance Imaging
12%
Amyloid Protein
12%
Biological Marker
12%
Mental Disorder
12%
Psychopathology
11%
Gamma-Aminobutyric Acid
11%
Ketamine
10%
Neuropsychiatric Symptom
10%
Placebo
10%
Blood Plasma
10%
Neurophysiology
10%
Glutamine
10%
Ventral Striatum
9%
Autism Spectrum Disorder
9%
Negative Syndrome
9%
Human Brain
8%
Receptor Occupancy
8%
Striatum
8%
Regression Analysis
8%
Cognitive Function
8%
Raclopride
8%
Frontal Lobe
7%
Hippocampus
7%
Cognitive Disorders
7%
Positive Syndrome
7%
Cortical Thickness
7%
Olanzapine
7%